Furthermore, emerging evidence identifies the combined biomarkers of elevated serum IL-6 levels and reduced BDNF concentrations as reliable predictors of depression severity (55), laying the foundation for multidimensional biomarker assessment systems. This evidence concerns the gene IL6 and depressive symptom measurement.